# Effects of Liothyronine on Energy Expenditure and Cardiovascular Function

> **NCT03098433** · PHASE1,PHASE2 · COMPLETED · sponsor: **Virginia Commonwealth University** · enrollment: 22 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Liothyronine
- **DRUG:** Levothyroxine
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT03098433
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-20
- **Primary completion:** 2019-06-24
- **Final completion:** 2019-06-24
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2021-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03098433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03098433, "Effects of Liothyronine on Energy Expenditure and Cardiovascular Function". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03098433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*